KR102396059B1 - 신규 화합물 및 이의 제조방법 - Google Patents
신규 화합물 및 이의 제조방법 Download PDFInfo
- Publication number
- KR102396059B1 KR102396059B1 KR1020197004436A KR20197004436A KR102396059B1 KR 102396059 B1 KR102396059 B1 KR 102396059B1 KR 1020197004436 A KR1020197004436 A KR 1020197004436A KR 20197004436 A KR20197004436 A KR 20197004436A KR 102396059 B1 KR102396059 B1 KR 102396059B1
- Authority
- KR
- South Korea
- Prior art keywords
- formula
- compound
- alkyl group
- hydrogen
- group
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1613054.4A GB201613054D0 (en) | 2016-07-28 | 2016-07-28 | New compound and process |
| GB1613054.4 | 2016-07-28 | ||
| PCT/GB2017/052190 WO2018020249A1 (en) | 2016-07-28 | 2017-07-27 | New compound and process |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| KR20190034231A KR20190034231A (ko) | 2019-04-01 |
| KR102396059B1 true KR102396059B1 (ko) | 2022-05-10 |
Family
ID=56936838
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1020197004436A Active KR102396059B1 (ko) | 2016-07-28 | 2017-07-27 | 신규 화합물 및 이의 제조방법 |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US10710998B2 (https=) |
| EP (1) | EP3490988B1 (https=) |
| JP (1) | JP6985367B2 (https=) |
| KR (1) | KR102396059B1 (https=) |
| CN (1) | CN109641891B (https=) |
| CY (1) | CY1122138T1 (https=) |
| DK (1) | DK3490988T3 (https=) |
| ES (1) | ES2751948T3 (https=) |
| GB (1) | GB201613054D0 (https=) |
| HR (1) | HRP20192109T1 (https=) |
| HU (1) | HUE046509T2 (https=) |
| LT (1) | LT3490988T (https=) |
| PL (1) | PL3490988T3 (https=) |
| PT (1) | PT3490988T (https=) |
| RS (1) | RS59566B1 (https=) |
| SI (1) | SI3490988T1 (https=) |
| SM (1) | SMT201900582T1 (https=) |
| TW (1) | TWI739871B (https=) |
| WO (1) | WO2018020249A1 (https=) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK3142701T3 (en) | 2014-05-12 | 2018-08-13 | Verona Pharma Plc | New treatment |
| GB201502260D0 (en) | 2015-02-11 | 2015-04-01 | Verona Pharma Plc | Salt of Pyrimido[6,1-A]Isoquinolin-4-one compound |
| PT4090654T (pt) * | 2020-01-17 | 2025-10-07 | Lupin Ltd | Métodos, processos e intermediários para a preparação de compostos de cromano |
| CN116917287A (zh) | 2021-04-29 | 2023-10-20 | 苏州盛迪亚生物医药有限公司 | 异喹啉酮类化合物及其用途 |
| JP2024545189A (ja) * | 2021-12-14 | 2024-12-05 | シーツァン ハイスコ ファーマスーティカル カンパニー リミテッド | 三環式縮合複素環系pde3/4二重阻害剤及びその用途 |
| GB202202297D0 (en) | 2022-02-21 | 2022-04-06 | Verona Pharma Plc | Formulation production process |
| EP4378942A1 (en) | 2022-12-02 | 2024-06-05 | Sandoz AG | Crystal form of a pde3/4 inhibitor |
| WO2025003643A1 (en) | 2023-06-26 | 2025-01-02 | Verona Pharma Plc | Particulate composition comprising ensifetrine |
| CN121620356A (zh) | 2023-06-26 | 2026-03-06 | 维罗纳制药公司 | 包含恩塞芬汀的颗粒组合物 |
| US20250073240A1 (en) | 2023-09-06 | 2025-03-06 | Verona Pharma Plc | New treatment |
| US20250249007A1 (en) | 2024-02-07 | 2025-08-07 | Verona Pharma Plc | Pharmaceutical compositions of ensifentrine for chronic obstructive pulmonary disease |
| WO2025168708A1 (en) | 2024-02-07 | 2025-08-14 | Verona Pharma Plc | Pharmaceutical compositions of ensifentrine for chronic obstructive pulmonary disease |
| WO2025176871A1 (en) | 2024-02-23 | 2025-08-28 | Inke, S.A. | Process for preparing pyrimido[6,1-a]isoquinoline-4-ones |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2000058308A1 (en) | 1999-03-31 | 2000-10-05 | Vernalis Limited | DERIVATIVES OF PYRIMIDO[6,1-a]ISOQUINOLIN-4-ONE |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ185900A (en) | 1976-12-10 | 1981-04-24 | Hoechst Ag | Pyrimido (6,1-a) isoquinolin-4-ones medicaments intermediate isoquinolines |
| FI64370C (fi) | 1977-05-05 | 1983-11-10 | Hoechst Ag | Foerfarande foer framstaellning av terapeutiskt anvaendbara pyimido-(6,1-a)isokinolin-2-imino-4-onderivat |
| DE2847693A1 (de) | 1978-11-03 | 1980-05-22 | Hoechst Ag | Verfahren zur herstellung von pyrimido-(6,1-a)-isochinolin-2-onen |
| DE3135831A1 (de) | 1981-09-10 | 1983-04-28 | Hoechst Ag, 6230 Frankfurt | 9,10-substituierte 2-mesitylimino-3-alkyl-3,4,6,7-tetrahydro-2h-pyrimido(6,1-a)isochinolin-4-one, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel |
| CA1237429A (en) | 1983-05-05 | 1988-05-31 | Frank Kienzle | Pyrimidone derivatives |
| PH12013500261A1 (en) | 2010-08-09 | 2013-03-04 | Verona Pharma Plc | Crystalline form of pyrimidio[6,1-a]isoquinolin-4-one compound |
| EP2968313B1 (en) | 2013-03-15 | 2018-01-31 | Verona Pharma PLC | Drug combination |
| DK3142701T3 (en) | 2014-05-12 | 2018-08-13 | Verona Pharma Plc | New treatment |
| CN110051627A (zh) | 2014-09-15 | 2019-07-26 | 维罗纳制药公司 | 包含rpl554的液体吸入制剂 |
| GB201502260D0 (en) | 2015-02-11 | 2015-04-01 | Verona Pharma Plc | Salt of Pyrimido[6,1-A]Isoquinolin-4-one compound |
-
2016
- 2016-07-28 GB GBGB1613054.4A patent/GB201613054D0/en not_active Ceased
-
2017
- 2017-07-27 PT PT177488806T patent/PT3490988T/pt unknown
- 2017-07-27 WO PCT/GB2017/052190 patent/WO2018020249A1/en not_active Ceased
- 2017-07-27 HU HUE17748880A patent/HUE046509T2/hu unknown
- 2017-07-27 DK DK17748880T patent/DK3490988T3/da active
- 2017-07-27 TW TW106125312A patent/TWI739871B/zh active
- 2017-07-27 EP EP17748880.6A patent/EP3490988B1/en active Active
- 2017-07-27 LT LTEP17748880.6T patent/LT3490988T/lt unknown
- 2017-07-27 SI SI201730098T patent/SI3490988T1/sl unknown
- 2017-07-27 PL PL17748880T patent/PL3490988T3/pl unknown
- 2017-07-27 RS RS20191474A patent/RS59566B1/sr unknown
- 2017-07-27 US US16/309,435 patent/US10710998B2/en active Active
- 2017-07-27 SM SM20190582T patent/SMT201900582T1/it unknown
- 2017-07-27 ES ES17748880T patent/ES2751948T3/es active Active
- 2017-07-27 HR HRP20192109TT patent/HRP20192109T1/hr unknown
- 2017-07-27 CN CN201780046788.1A patent/CN109641891B/zh active Active
- 2017-07-27 JP JP2019503748A patent/JP6985367B2/ja active Active
- 2017-07-27 KR KR1020197004436A patent/KR102396059B1/ko active Active
-
2019
- 2019-10-04 CY CY20191101046T patent/CY1122138T1/el unknown
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2000058308A1 (en) | 1999-03-31 | 2000-10-05 | Vernalis Limited | DERIVATIVES OF PYRIMIDO[6,1-a]ISOQUINOLIN-4-ONE |
Non-Patent Citations (1)
| Title |
|---|
| Journal of Medical Chemistry, Vol. 27(11), pp. 1470-1480(1984) |
Also Published As
| Publication number | Publication date |
|---|---|
| SMT201900582T1 (it) | 2019-11-13 |
| CY1122138T1 (el) | 2020-11-25 |
| JP2019527228A (ja) | 2019-09-26 |
| TWI739871B (zh) | 2021-09-21 |
| SI3490988T1 (sl) | 2019-11-29 |
| KR20190034231A (ko) | 2019-04-01 |
| PL3490988T3 (pl) | 2020-02-28 |
| EP3490988A1 (en) | 2019-06-05 |
| US10710998B2 (en) | 2020-07-14 |
| HRP20192109T1 (hr) | 2020-02-21 |
| US20190330206A1 (en) | 2019-10-31 |
| HUE046509T2 (hu) | 2020-03-30 |
| JP6985367B2 (ja) | 2021-12-22 |
| DK3490988T3 (da) | 2019-10-28 |
| GB201613054D0 (en) | 2016-09-14 |
| WO2018020249A1 (en) | 2018-02-01 |
| RS59566B1 (sr) | 2019-12-31 |
| EP3490988B1 (en) | 2019-08-28 |
| LT3490988T (lt) | 2019-10-10 |
| PT3490988T (pt) | 2019-10-28 |
| CN109641891A (zh) | 2019-04-16 |
| ES2751948T3 (es) | 2020-04-02 |
| TW201806951A (zh) | 2018-03-01 |
| CN109641891B (zh) | 2021-05-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR102396059B1 (ko) | 신규 화합물 및 이의 제조방법 | |
| CN116987112B (zh) | 制备氨基嘧啶衍生物的改善方法 | |
| TW201713652A (zh) | 雜環化合物的合成 | |
| CN113767094B (zh) | 3-甲基-1,2,4-噻二唑-5-碳酰肼及其甲基-d3氘代形式的合成 | |
| EP3303304B1 (en) | Methods of making protein deacetylase inhibitors | |
| TW201625634A (zh) | 科帕利普(copanlisib)及其二鹽酸鹽之合成 | |
| EA038078B1 (ru) | Промежуточные соединения, используемые для синтеза селективного ингибитора протеинкиназы, и способы их получения | |
| EP4313987B1 (en) | Process for the preparation of ribociclib and pharmaceutically acceptable salts thereof | |
| CN112824381A (zh) | 一种哌啶胺的制备方法 | |
| WO2013059572A1 (en) | Process for the preparation of etravirine and intermediates in the synthesis thereof | |
| HK40002783B (en) | New compound and process | |
| HK40002783A (en) | New compound and process | |
| CN113816955B (zh) | 一种ret激酶抑制剂中间体及其制备方法 | |
| US6340773B1 (en) | Preparation of halogenated primary amines | |
| CN105849115A (zh) | 制药方法和中间体 | |
| US11780824B2 (en) | Process for preparing osimertinib or a salt thereof | |
| RU2804686C2 (ru) | СИНТЕЗ 3-МЕТИЛ-1,2,4-ТИАДИАЗОЛ-5-КАРБОГИДРАЗИДА ИЛИ ЕГО МЕТИЛ-d3 ДЕЙТЕРИРОВАННОЙ ФОРМЫ | |
| CN119638647A (zh) | 制备氧杂环丁烷-2-基甲胺或其盐的方法 | |
| CN121511241A (zh) | 化合物的新制备方法及新结晶形式 | |
| KR20260049231A (ko) | 아비박탐 및 이의 중간체를 제조하기 위한 개선된 방법 | |
| JP2024080578A (ja) | ミラベグロン及びその製造中間体の製造方法 | |
| CN120936603A (zh) | 并环化合物的制备方法及其中间体 | |
| CN120424067A (zh) | 并环化合物的制备方法及其中间体 | |
| WO2024251227A1 (zh) | 一种甲酰胺类化合物的制备方法 | |
| KR20240038024A (ko) | B형 간염 바이러스 뉴클레오캡시드 억제제의 제조 방법 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PA0105 | International application |
St.27 status event code: A-0-1-A10-A15-nap-PA0105 |
|
| PG1501 | Laying open of application |
St.27 status event code: A-1-1-Q10-Q12-nap-PG1501 |
|
| A201 | Request for examination | ||
| P11-X000 | Amendment of application requested |
St.27 status event code: A-2-2-P10-P11-nap-X000 |
|
| P13-X000 | Application amended |
St.27 status event code: A-2-2-P10-P13-nap-X000 |
|
| PA0201 | Request for examination |
St.27 status event code: A-1-2-D10-D11-exm-PA0201 |
|
| P11-X000 | Amendment of application requested |
St.27 status event code: A-2-2-P10-P11-nap-X000 |
|
| P13-X000 | Application amended |
St.27 status event code: A-2-2-P10-P13-nap-X000 |
|
| E902 | Notification of reason for refusal | ||
| PE0902 | Notice of grounds for rejection |
St.27 status event code: A-1-2-D10-D21-exm-PE0902 |
|
| P11-X000 | Amendment of application requested |
St.27 status event code: A-2-2-P10-P11-nap-X000 |
|
| P13-X000 | Application amended |
St.27 status event code: A-2-2-P10-P13-nap-X000 |
|
| E701 | Decision to grant or registration of patent right | ||
| PE0701 | Decision of registration |
St.27 status event code: A-1-2-D10-D22-exm-PE0701 |
|
| GRNT | Written decision to grant | ||
| PR0701 | Registration of establishment |
St.27 status event code: A-2-4-F10-F11-exm-PR0701 |
|
| PR1002 | Payment of registration fee |
St.27 status event code: A-2-2-U10-U12-oth-PR1002 Fee payment year number: 1 |
|
| PG1601 | Publication of registration |
St.27 status event code: A-4-4-Q10-Q13-nap-PG1601 |
|
| PR1001 | Payment of annual fee |
St.27 status event code: A-4-4-U10-U11-oth-PR1001 Fee payment year number: 4 |
|
| U11 | Full renewal or maintenance fee paid |
Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U11-OTH-PR1001 (AS PROVIDED BY THE NATIONAL OFFICE) Year of fee payment: 4 |